Search results
Displaying Results 981-990 of 13853 for "❤️推荐三上悠亚唯一无码作品，请访问 【】❤️推荐"
Warburg Pincus leads Series C for China AI drug developer
Insilico Medicine, which leverages artificial intelligence (AI) technology to speed up the drug development process, has closed a $255 million Series C funding round led by Warburg Pincus.
PE investors agree $5.7b 51job take-private
A consortium led by DCP Capital Partners has finalized terms for a $5.7 billion privatization of US-listed Chinese online recruitment platform 51job.
Deal focus: Australia's ENA hits COVID-19 in the nose
Australian investors see hope in ENA Respiratory, a nasal spray specialist aiming to complement global COVID-19 vaccine programs with an immune system-boosting product
Quadrant buys Australia's Affinity Education from Anchorage
Quadrant Private Equity has acquired Australia-based childcare business Affinity Education from Anchorage Capital Partners for A$650 million ($490 million).
KKR buys controlling stake in India's Vini Cosmetics
KKR has agreed to pay $625 million for a controlling stake in Vini Cosmetics, a leading branded personal care and beauty products company in India.
Singapore gene therapy start-up closes $24m Series A
Nuevocor, a preclinical biotech company specializing in gene therapy for heart disease, has closed an oversubscribed Series A round with $24 million in commitments.
Apis leads $45m Series C for India's RenewBuy
Apis Partners has led a $45 million Series C round for RenewBuy, an India insurance comparison platform specializing in motor insurance.
Fidelity backs $131m Series A for China citytech platform Venturous
Venturous Group, a Chinese smart city platform, has received $131 million in Series A funding from Fidelity, several family offices, and Benson Tan, founder of Venturous.
PE-backed China Youran Dairy loses ground after $643m HK IPO
PAG Asia Capital-backed China Youran Dairy Group raised HK$4.99 billion ($643 million) through a Hong Kong IPO but then ended its trading debut below the IPO price.
New Zealand's Oriens hits $56m Fund II target
New Zealand private equity firm Oriens Capital has hit the NZ$80 million ($56 million) target for its second fund and is now seeking NZ$20 million in oversubscriptions.